US2040108A
(en)
|
1935-04-11 |
1936-05-12 |
Air Reduction |
Recovery of krypton and xenon
|
CU22545A1
(es)
|
1994-11-18 |
1999-03-31 |
Centro Inmunologia Molecular |
Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
ATE37983T1
(de)
|
1982-04-22 |
1988-11-15 |
Ici Plc |
Mittel mit verzoegerter freigabe.
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
FR2556739A1
(fr)
|
1983-12-19 |
1985-06-21 |
Pasteur Institut |
Lignees cellulaires secretant des anticorps monoclonaux contre la pg e2, leur preparation, les anticorps obtenus et leur application
|
US4753894A
(en)
|
1984-02-08 |
1988-06-28 |
Cetus Corporation |
Monoclonal anti-human breast cancer antibodies
|
US4943533A
(en)
|
1984-03-01 |
1990-07-24 |
The Regents Of The University Of California |
Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
DE3590766T
(ja)
|
1985-03-30 |
1987-04-23 |
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
DE3683541D1
(de)
|
1985-06-07 |
1992-03-05 |
Ici America Inc |
Selektionierte difluorverbindungen.
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
DE3750503T2
(de)
|
1986-10-22 |
1995-02-09 |
Abbott Lab |
Chemilumineszierende Acridinium- und Phenantridiniumsalze.
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
US5006309A
(en)
|
1988-04-22 |
1991-04-09 |
Abbott Laboratories |
Immunoassay device with liquid transfer between wells by washing
|
US5089424A
(en)
|
1988-06-14 |
1992-02-18 |
Abbott Laboratories |
Method and apparatus for heterogeneous chemiluminescence assay
|
EP1892296A1
(en)
|
1988-09-02 |
2008-02-27 |
Dyax Corporation |
Generation and selection of recombinant varied binding proteins
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5241070A
(en)
|
1988-09-26 |
1993-08-31 |
Ciba Corning Diagnostics Corp. |
Nucleophilic polysubstituted aryl acridinium esters and uses thereof
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
SE462454B
(sv)
|
1988-11-10 |
1990-06-25 |
Pharmacia Ab |
Maetyta foer anvaendning i biosensorer
|
AU634186B2
(en)
|
1988-11-11 |
1993-02-18 |
Medical Research Council |
Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
|
US5063081A
(en)
|
1988-11-14 |
1991-11-05 |
I-Stat Corporation |
Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
CA2057923A1
(en)
|
1989-05-16 |
1990-11-17 |
William D. Huse |
Co-expression of heteromeric receptors
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
WO1991005548A1
(en)
|
1989-10-10 |
1991-05-02 |
Pitman-Moore, Inc. |
Sustained release composition for macromolecular proteins
|
CA2071867A1
(en)
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
AT396939B
(de)
|
1990-05-29 |
1993-12-27 |
Alois Dipl Ing Dr Jungbauer |
Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
EP0585287B1
(en)
|
1990-07-10 |
1999-10-13 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
EP0542810A1
(en)
|
1990-08-02 |
1993-05-26 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
US5135875A
(en)
|
1990-08-15 |
1992-08-04 |
Abbott Laboratories |
Protein precipitation reagent
|
WO1992003461A1
(en)
|
1990-08-24 |
1992-03-05 |
Ixsys, Inc. |
Methods of synthesizing oligonucleotides with random codons
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
DK0564531T3
(da)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
US5780279A
(en)
|
1990-12-03 |
1998-07-14 |
Genentech, Inc. |
Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
|
NZ241119A
(en)
|
1990-12-20 |
1993-06-25 |
Ixsys Inc |
Manipulating nucleic acid to optimize the binding characteristics of the encoded binding protein
|
AU1545692A
(en)
|
1991-03-01 |
1992-10-06 |
Protein Engineering Corporation |
Process for the development of binding mini-proteins
|
DE69233153T2
(de)
|
1991-03-06 |
2004-05-27 |
Merck Patent Gmbh |
Humanisierte monoklonale antikörper
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
JPH06506120A
(ja)
|
1991-03-18 |
1994-07-14 |
ニューヨーク・ユニバーシティ |
ヒト腫瘍壊死因子に特異的なモノクローナルなキメラ抗体
|
ATE269401T1
(de)
|
1991-04-10 |
2004-07-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
WO1992019759A1
(en)
|
1991-04-25 |
1992-11-12 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
EP0583356B1
(en)
|
1991-05-01 |
2002-07-31 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
A method for treating infectious respiratory diseases
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
DE4118120A1
(de)
|
1991-06-03 |
1992-12-10 |
Behringwerke Ag |
Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
|
CA2069530A1
(en)
|
1991-06-03 |
1992-12-04 |
Cass J. Grandone |
Reagent pack for immunoassays
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
JPH07503124A
(ja)
|
1991-06-14 |
1995-04-06 |
ゾーマ・コーポレーション |
微生物によって生産される抗体断片とそれらの複合体
|
LU91067I2
(fr)
|
1991-06-14 |
2004-04-02 |
Genentech Inc |
Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
DK0605522T3
(da)
|
1991-09-23 |
2000-01-17 |
Medical Res Council |
Fremgangsmåde til fremstilling af humaniserede antistoffer
|
WO1993011161A1
(en)
|
1991-11-25 |
1993-06-10 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
CA2507749C
(en)
|
1991-12-13 |
2010-08-24 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
US5352803A
(en)
|
1992-03-30 |
1994-10-04 |
Abbott Laboratories |
5(6)-methyl substituted fluorescein derivatives
|
EP0649533B1
(en)
|
1992-03-30 |
2000-05-10 |
Abbott Laboratories |
Reagents and methods for the detection and quantification of thyroxine in fluid samples
|
JPH07509137A
(ja)
|
1992-07-24 |
1995-10-12 |
セル ジェネシス,インク. |
異種抗体の生産
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
EP1005870B1
(en)
|
1992-11-13 |
2009-01-21 |
Biogen Idec Inc. |
Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
WO1994018219A1
(en)
|
1993-02-02 |
1994-08-18 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
WO1995001997A1
(en)
*
|
1993-07-09 |
1995-01-19 |
Smithkline Beecham Corporation |
RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
|
WO1995009917A1
(en)
|
1993-10-07 |
1995-04-13 |
The Regents Of The University Of California |
Genetically engineered bispecific tetravalent antibodies
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
US5565352A
(en)
|
1993-11-24 |
1996-10-15 |
Arch Development Corporation |
Deubiquitinating enzyme: compositions and methods
|
JPH09506262A
(ja)
|
1993-12-08 |
1997-06-24 |
ジェンザイム・コーポレイション |
特異的抗体の製造方法
|
JPH09506260A
(ja)
|
1993-12-10 |
1997-06-24 |
アボツト・ラボラトリーズ |
メトトレキサートを検出するための試薬および方法
|
GB9401182D0
(en)
|
1994-01-21 |
1994-03-16 |
Inst Of Cancer The Research |
Antibodies to EGF receptor and their antitumour effect
|
AU1736495A
(en)
|
1994-01-31 |
1995-08-15 |
Trustees Of Boston University |
Polyclonal antibody libraries
|
ZA95960B
(en)
|
1994-03-14 |
1995-10-10 |
Genetics Inst |
Use of interleukin-12 antagonists in the treatment of autoimmune diseases
|
AU2071695A
(en)
|
1994-03-17 |
1995-10-03 |
Merck Patent Gmbh |
Anti-EGFR single-chain FVS and anti-EGFR antibodies
|
IL109632A
(en)
|
1994-05-11 |
2007-03-08 |
Yeda Res & Dev |
Modulators of the function of tnf receptors
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
DE69534530T2
(de)
|
1994-08-12 |
2006-07-06 |
Immunomedics, Inc. |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
WO1996020698A2
(en)
|
1995-01-05 |
1996-07-11 |
The Board Of Regents Acting For And On Behalf Of The University Of Michigan |
Surface-modified nanoparticles and method of making and using same
|
GB9504344D0
(en)
|
1995-03-03 |
1995-04-19 |
Unilever Plc |
Antibody fragment production
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
JPH11503914A
(ja)
|
1995-04-21 |
1999-04-06 |
セル ジェネシス,インコーポレイテッド |
大ゲノムdna欠失の生成
|
EP1709970A1
(en)
|
1995-04-27 |
2006-10-11 |
Abgenix, Inc. |
Human antibodies against EGFR, derived from immunized xenomice
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US7060808B1
(en)
|
1995-06-07 |
2006-06-13 |
Imclone Systems Incorporated |
Humanized anti-EGF receptor monoclonal antibody
|
CA2222231A1
(en)
|
1995-06-07 |
1996-12-19 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth of tumors
|
US6127977A
(en)
|
1996-11-08 |
2000-10-03 |
Cohen; Nathan |
Microstrip patch antenna with fractal structure
|
WO1997007788A2
(en)
|
1995-08-31 |
1997-03-06 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
AU6873396A
(en)
|
1995-10-16 |
1997-05-07 |
Unilever N.V. |
A bifunctional or bivalent antibody fragment analogue
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
US6331431B1
(en)
|
1995-11-28 |
2001-12-18 |
Ixsys, Inc. |
Vacuum device and method for isolating periplasmic fraction from cells
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
DE69721548T2
(de)
|
1996-02-09 |
2004-04-01 |
Abbott Laboratories(Bermuda)Ltd. |
HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN
|
US5985320A
(en)
|
1996-03-04 |
1999-11-16 |
The Penn State Research Foundation |
Materials and methods for enhancing cellular internalization
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
EP0889964A1
(en)
|
1996-03-28 |
1999-01-13 |
The Johns Hopkins University |
Soluble divalent and multivalent heterodimeric analogs of proteins
|
ES2225961T3
(es)
|
1996-04-04 |
2005-03-16 |
Unilever N.V. |
Proteina de union a antigeno multivalente y multiespecifica.
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
US6986890B1
(en)
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
US7258857B2
(en)
|
1996-11-22 |
2007-08-21 |
The Trustees Of Columbia University In The City Of New York |
Rage-related methods for treating inflammation
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
CA2277801C
(en)
|
1997-01-16 |
2002-10-15 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
ATE529509T1
(de)
|
1997-01-21 |
2011-11-15 |
Gen Hospital Corp |
Selektion von proteinen unter verwendung von rna- protein-fusionen
|
US7306914B2
(en)
|
1997-01-31 |
2007-12-11 |
Odyssey Thera Inc. |
Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
KR100870353B1
(ko)
|
1997-04-07 |
2008-11-25 |
제넨테크, 인크. |
항-vegf 항체
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
WO1999006834A2
(en)
|
1997-08-04 |
1999-02-11 |
Ixsys, Incorporated |
Methods for identifying ligand specific binding molecules
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
DE69841562D1
(de)
|
1997-10-27 |
2010-04-29 |
Bac Ip Bv |
Multivalente antigenbindende proteine
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
CA2322749A1
(en)
|
1998-03-03 |
1999-09-10 |
Abgenix, Inc. |
Cd147 binding molecules as therapeutics
|
WO1999051773A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
US6489447B1
(en)
|
1998-05-06 |
2002-12-03 |
Genentech, Inc. |
Protein purification
|
AU747231B2
(en)
|
1998-06-24 |
2002-05-09 |
Alkermes, Inc. |
Large porous particles emitted from an inhaler
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
WO2000006560A1
(en)
|
1998-07-30 |
2000-02-10 |
Warner-Lambert Company |
Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
|
EP1105427A2
(en)
|
1998-08-17 |
2001-06-13 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
US20030215458A1
(en)
|
1998-09-30 |
2003-11-20 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
WO2000034337A1
(en)
|
1998-12-10 |
2000-06-15 |
Tsukuba Research Laboratory, Toagosei Co., Ltd. |
Humanized monoclonal antibodies against vascular endothelial cell growth factor
|
IL143797A0
(en)
|
1998-12-23 |
2002-04-21 |
Pfizer |
Human monoclonal antibodies to cytotoxic t lymphocyte antigen 4
|
US8003772B2
(en)
|
1999-01-14 |
2011-08-23 |
Martek Biosciences Corporation |
Chimeric PUFA polyketide synthase systems and uses thereof
|
PL209786B1
(pl)
|
1999-01-15 |
2011-10-31 |
Genentech Inc |
Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
|
AU4025300A
(en)
|
1999-03-24 |
2000-10-09 |
Packard Bioscience Company |
Continuous porous matrix arrays
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
JP4841038B2
(ja)
|
1999-03-25 |
2011-12-21 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
ヒトil−12に結合するヒト抗体およびその産生法
|
DK2275540T3
(en)
|
1999-04-09 |
2016-05-09 |
Kyowa Hakko Kirin Co Ltd |
Method for controlling the activity of immunologically functional molecule.
|
CN1119415C
(zh)
|
1999-06-04 |
2003-08-27 |
长春迈灵生物工程有限公司 |
抗ca125双功能基因工程抗体的克隆与表达
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
US6531580B1
(en)
|
1999-06-24 |
2003-03-11 |
Ixsys, Inc. |
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
PT2283867E
(pt)
|
1999-06-25 |
2014-08-29 |
Immunogen Inc |
Métodos de tratamento usando conjugados de anticorpo antierbb- maitansinóide
|
EP1230269A2
(en)
|
1999-11-03 |
2002-08-14 |
Maxygen, Inc. |
Antibody diversity generation
|
PL356836A1
(en)
|
2000-02-10 |
2004-07-12 |
Abbott Laboratories |
Antibodies that bind human interleukin-18 and methods of making and using
|
KR20020082227A
(ko)
|
2000-02-24 |
2002-10-30 |
제넨테크, 인크. |
카스파제 활성화 전구약물 요법
|
US7129332B2
(en)
|
2000-02-25 |
2006-10-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
|
US7094566B2
(en)
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
PL358215A1
(en)
|
2000-03-24 |
2004-08-09 |
Micromet Ag |
Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
CA2407956A1
(en)
|
2000-05-03 |
2001-11-08 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
DE60116753T2
(de)
|
2000-05-19 |
2006-09-14 |
Scancell Ltd. |
Humanisierte antikörper gegen den epidermalen wachstumsfaktorrezeptor
|
ATE309385T1
(de)
|
2000-06-28 |
2005-11-15 |
Glycofi Inc |
Verfahren für die herstellung modifizierter glykoproteine
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
EP2899210A3
(en)
|
2000-06-29 |
2015-11-18 |
Abbvie Inc. |
Dual specificity antibodies and methods of making and using
|
CA2410551A1
(en)
|
2000-06-30 |
2002-01-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw (Vib) |
Heterodimeric fusion proteins
|
US20090081234A1
(en)
|
2000-08-07 |
2009-03-26 |
George Heavner |
Anti-tnf antibodies, compositions, methods and uses for treatment of depression and related conditions
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
GB0020685D0
(en)
|
2000-08-22 |
2000-10-11 |
Novartis Ag |
Organic compounds
|
US20030157643A1
(en)
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
EP1343820A4
(en)
*
|
2000-10-13 |
2005-09-14 |
Uab Research Foundation |
ANTI-EPIDERMIC GROWTH FACTOR RECEPTOR SINGLE CHAIN ANTIBODY
|
ATE338124T1
(de)
|
2000-11-07 |
2006-09-15 |
Hope City |
Cd19-spezifische umgezielte immunzellen
|
US7601692B2
(en)
|
2000-11-28 |
2009-10-13 |
Compugen Ltd. |
MCP-1 splice variants and methods of using same
|
US6818392B2
(en)
|
2000-12-06 |
2004-11-16 |
Abbott Laboratories |
Monoclonal antibodies to human immunodeficiency virus and uses thereof
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
CA2433353C
(en)
|
2000-12-28 |
2017-03-21 |
Altus Biologics, Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
CN1330668C
(zh)
|
2001-01-05 |
2007-08-08 |
辉瑞大药厂 |
胰岛素样生长因子i受体的抗体
|
US7667004B2
(en)
|
2001-04-17 |
2010-02-23 |
Abmaxis, Inc. |
Humanized antibodies against vascular endothelial growth factor
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
US20030157105A1
(en)
|
2001-05-30 |
2003-08-21 |
Carton Jill M. |
Anti-p40 immunglobulin derived proteins, compositions, methods and uses
|
CA2975521A1
(en)
|
2001-05-30 |
2002-12-05 |
Genentech, Inc. |
Anti-ngf antibodies for the treatment of various disorders
|
IL159225A0
(en)
|
2001-06-13 |
2004-06-01 |
Genmab As |
Human monoclonal antibodies to epidermal growth factor receptor (egfr)
|
US20060073141A1
(en)
|
2001-06-28 |
2006-04-06 |
Domantis Limited |
Compositions and methods for treating inflammatory disorders
|
JP4249013B2
(ja)
|
2001-07-31 |
2009-04-02 |
佑 本庶 |
Pd−1に対し特異性を有する物質
|
EP1432444A4
(en)
|
2001-08-17 |
2005-11-02 |
Lilly Co Eli |
ANTI-BETA ANTIBODIES
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
US20030226155A1
(en)
|
2001-08-30 |
2003-12-04 |
Biorexis Pharmaceutical Corporation |
Modified transferrin-antibody fusion proteins
|
HUP0402049A3
(en)
|
2001-09-25 |
2009-04-28 |
Astellas Pharma Inc |
Recombinant anti-osteopontin antibody and use thereof
|
ATE434040T1
(de)
|
2001-10-01 |
2009-07-15 |
Dyax Corp |
Mehrkettige eukaryontische display-vektoren und deren verwendungen
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
EP1443961B1
(en)
|
2001-10-25 |
2009-05-06 |
Genentech, Inc. |
Glycoprotein compositions
|
AU2002346373A1
(en)
|
2001-11-09 |
2003-05-19 |
Idec Pharmaceuticals Corporation |
Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
|
DE10156482A1
(de)
|
2001-11-12 |
2003-05-28 |
Gundram Jung |
Bispezifisches Antikörper-Molekül
|
EP2308888B1
(en)
|
2001-11-14 |
2017-03-01 |
Janssen Biotech, Inc. |
Anti-IL-6 antibodies, compositions, methods and uses
|
US7452539B2
(en)
|
2001-12-19 |
2008-11-18 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
ATE417858T1
(de)
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
CA2472922A1
(en)
|
2002-02-11 |
2003-08-21 |
Genentech, Inc. |
Antibody variants with faster antigen association rates
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
US7419821B2
(en)
|
2002-03-05 |
2008-09-02 |
I-Stat Corporation |
Apparatus and methods for analyte measurement and immunoassay
|
CA2481747A1
(en)
|
2002-04-12 |
2003-10-23 |
Medimmune, Inc. |
Recombinant anti-interleukin-9 antibodies
|
JP2006512891A
(ja)
|
2002-04-18 |
2006-04-20 |
ジェネンコー・インターナショナル・インク |
糸状菌における機能性抗体の生産
|
AU2003265235A1
(en)
|
2002-04-26 |
2003-12-19 |
Genetech, Inc. |
Non-affinity purification of proteins
|
US20030206898A1
(en)
|
2002-04-26 |
2003-11-06 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
ES2333952T3
(es)
|
2002-04-30 |
2010-03-03 |
Kyowa Hakko Kirin Co., Ltd. |
Anticuerpo para el factor de crecimiento humano de tipo insulinico.
|
US7714189B2
(en)
|
2002-05-03 |
2010-05-11 |
Monsanto Technology Llc |
High tryptophan maize
|
EP2316922B1
(en)
|
2002-05-24 |
2013-05-22 |
Merck Sharp & Dohme Corp. |
Neutralizing human anti-IGFR antibody
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
CN1678634A
(zh)
|
2002-06-28 |
2005-10-05 |
多曼蒂斯有限公司 |
免疫球蛋白单个变体抗原结合区及其特异性构建体
|
PT1523496E
(pt)
|
2002-07-18 |
2011-09-29 |
Merus B V |
Produção de misturas de anticorpos de forma recombinante
|
US20040018577A1
(en)
|
2002-07-29 |
2004-01-29 |
Emerson Campbell John Lewis |
Multiple hybrid immunoassay
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
RS20050834A
(en)
|
2002-08-19 |
2007-12-31 |
Abgenix Inc., |
Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
|
EP1543038B2
(en)
|
2002-09-11 |
2020-08-05 |
Genentech, Inc. |
Protein purification
|
US7820166B2
(en)
|
2002-10-11 |
2010-10-26 |
Micromet Ag |
Potent T cell modulating molecules
|
CA2704070A1
(en)
|
2002-11-22 |
2004-06-10 |
Eisai R&D Management Co., Ltd. |
Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
|
CN100434440C
(zh)
|
2002-12-02 |
2008-11-19 |
阿布格尼克斯公司 |
针对肿瘤坏死因子的抗体及其用途
|
KR20070055625A
(ko)
|
2002-12-16 |
2007-05-30 |
제넨테크, 인크. |
이뮤노글로불린 변이체 및 이들의 용도
|
PT2270048E
(pt)
|
2002-12-24 |
2016-02-10 |
Rinat Neuroscience Corp |
Anticorpos anti-ngf e métodos de utilização dos mesmos
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
JP3803790B2
(ja)
|
2003-02-17 |
2006-08-02 |
株式会社東北テクノアーチ |
新規なダイアボディ型二重特異性抗体
|
PL2163643T3
(pl)
|
2003-03-05 |
2015-06-30 |
Halozyme Inc |
Rozpuszczalna glikoproteina o aktywności hialuronidazy (sHASEGP), sposób jej wytwarzania, zastosowania oraz zawierające ją kompozycje farmaceutyczne
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
EP1622942B1
(en)
|
2003-05-01 |
2014-11-19 |
ImClone LLC |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
EP1633382A4
(en)
|
2003-05-14 |
2009-08-05 |
Dow Corning |
REPEAT SEQUENCE PROTEIN-POLYMER-ACTIVE CONJUGATE, METHOD AND USES
|
US20070104722A1
(en)
|
2003-05-15 |
2007-05-10 |
Iogenetics |
Targeted biocides
|
EP1629012B1
(en)
|
2003-05-31 |
2018-11-28 |
Amgen Research (Munich) GmbH |
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
|
SG131943A1
(en)
|
2003-07-18 |
2007-05-28 |
Amgen Inc |
Specific binding agents to hepatocyte growth factor
|
DK1648940T3
(en)
|
2003-07-28 |
2016-08-15 |
Genentech Inc |
Reduction of leaching of protein A during protein A affinity chromatography
|
US20050026881A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
WO2005044853A2
(en)
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
US7662928B2
(en)
|
2003-08-08 |
2010-02-16 |
The Research Foundation Of State University Of New York |
Anti-FcRn antibodies for treatment of auto/allo immune conditions
|
WO2005018572A2
(en)
|
2003-08-22 |
2005-03-03 |
Biogen Idec Ma Inc. |
Improved antibodies having altered effector function and methods for making the same
|
CA2537055A1
(en)
|
2003-08-22 |
2005-04-21 |
Medimmune, Inc. |
Humanization of antibodies
|
US7682833B2
(en)
|
2003-09-10 |
2010-03-23 |
Abbott Point Of Care Inc. |
Immunoassay device with improved sample closure
|
US7723099B2
(en)
|
2003-09-10 |
2010-05-25 |
Abbott Point Of Care Inc. |
Immunoassay device with immuno-reference electrode
|
US20060134105A1
(en)
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
US20050180974A1
(en)
|
2003-10-24 |
2005-08-18 |
Medtronic, Inc. |
Extracellular TNF inhibitors for treating CNS disorders
|
US7968684B2
(en)
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
WO2005051295A2
(en)
|
2003-11-21 |
2005-06-09 |
Anp Technologies, Inc. |
Asymmetrically branched polymer conjugates and microarray assays
|
WO2005056759A2
(en)
|
2003-12-04 |
2005-06-23 |
Xencor, Inc. |
Methods of generating variant proteins with increased host string content and compositions thereof
|
EP1691822A4
(en)
|
2003-12-09 |
2008-01-02 |
Ventria Bioscience |
HIGH-LEVEL EXPRESSION OF FUSION POLYPEPTIDES IN VEGETABLE SEEDS USING SEED PRESERVATION PROTEINS AS FUSION PROTEIN MEDIA
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
ITRM20030601A1
(it)
|
2003-12-24 |
2005-06-25 |
Lay Line Genomics Spa |
Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
|
US7297541B2
(en)
|
2004-01-26 |
2007-11-20 |
Monsanto Technology Llc |
Genes encoding 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
CA2562771C
(en)
|
2004-04-12 |
2013-04-09 |
Medimmune, Inc. |
Anti-il-9 antibody formulations and uses thereof
|
JP2007535317A
(ja)
|
2004-04-15 |
2007-12-06 |
グライコフィ, インコーポレイテッド |
下等真核生物におけるガラクトシル化された糖タンパク質の産生
|
WO2005111082A1
(en)
|
2004-04-30 |
2005-11-24 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-tfr antibody.
|
EP1773881A4
(en)
|
2004-05-13 |
2008-08-06 |
Imclone Systems Inc |
Inhibition of macrophage-stimulating protein receptor (RON)
|
US20080115243A1
(en)
|
2004-05-19 |
2008-05-15 |
Agrivida, Inc. |
Transgenic Plants Expressing Intein Modified Proteins and Associated Processes for Bio-Pharmaceutical Production
|
WO2006001965A2
(en)
|
2004-05-24 |
2006-01-05 |
Abgenix, Inc. |
Reducing the risk of human anti-human antibodies through v gene manipulation
|
AU2005250499B2
(en)
|
2004-06-03 |
2011-12-08 |
Novimmune S.A. |
Anti-CD3 antibodies and methods of use thereof
|
US7150969B2
(en)
|
2004-06-04 |
2006-12-19 |
Rosetta Inpharmatics Llc |
Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
|
EP1786918A4
(en)
|
2004-07-17 |
2009-02-11 |
Imclone Systems Inc |
NEW BISPECIFIC ANTIBODY TETRAVALENT
|
US7709611B2
(en)
|
2004-08-04 |
2010-05-04 |
Amgen Inc. |
Antibodies to Dkk-1
|
WO2006015371A2
(en)
|
2004-08-05 |
2006-02-09 |
Genentech, Inc. |
Humanized anti-cmet antagonists
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
US20060067930A1
(en)
|
2004-08-19 |
2006-03-30 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
GB0419424D0
(en)
|
2004-09-02 |
2004-10-06 |
Viragen Scotland Ltd |
Transgene optimisation
|
CN101094868B
(zh)
|
2004-09-03 |
2013-07-10 |
健泰科生物技术公司 |
人源化的抗-β7拮抗剂及其应用
|
JP2008520186A
(ja)
|
2004-10-01 |
2008-06-19 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
哺乳類eag1イオンチャネルタンパク質に対する新規の抗体
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
WO2006047350A2
(en)
|
2004-10-21 |
2006-05-04 |
Xencor, Inc. |
IgG IMMUNOGLOBULIN VARIANTS WITH OPTIMIZED EFFECTOR FUNCTION
|
US20060253100A1
(en)
|
2004-10-22 |
2006-11-09 |
Medtronic, Inc. |
Systems and Methods to Treat Pain Locally
|
SG156672A1
(en)
|
2004-10-22 |
2009-11-26 |
Amgen Inc |
Methods for refolding of recombinant antibodies
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
US20070135620A1
(en)
|
2004-11-12 |
2007-06-14 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
AU2005313971B2
(en)
|
2004-12-08 |
2011-10-13 |
Immunomedics, Inc. |
Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
|
JP2008524247A
(ja)
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのアミロイドβ抗体
|
CA2595610C
(en)
*
|
2004-12-21 |
2013-03-05 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
WO2006118617A2
(en)
|
2004-12-23 |
2006-11-09 |
Chlorogen, Inc. |
EXPRESSING TGF-β PROTEINS IN PLANT PLASTIDS
|
AU2006208286A1
(en)
|
2005-01-26 |
2006-08-03 |
Amgen Fremont Inc. |
Antibodies against interleukin-1 beta
|
JP5651285B2
(ja)
|
2005-02-15 |
2015-01-07 |
デューク ユニバーシティ |
抗cd19抗体および腫瘍学における使用
|
US20060263357A1
(en)
|
2005-05-05 |
2006-11-23 |
Tedder Thomas F |
Anti-CD19 antibody therapy for autoimmune disease
|
JP4942644B2
(ja)
|
2005-02-28 |
2012-05-30 |
株式会社抗体研究所 |
抗IgSF4抗体及びその利用
|
MX2007011735A
(es)
|
2005-03-24 |
2008-03-14 |
Thrombogenics Nv |
Anticuerpo anti-plgf novedoso.
|
AU2006232920B2
(en)
|
2005-04-06 |
2011-09-29 |
Ibc Pharmaceuticals, Inc. |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
|
EP2295466A3
(en)
|
2005-04-25 |
2011-08-17 |
Pfizer Inc. |
Antibodies to myostatin
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
AU2006244014B2
(en)
|
2005-05-10 |
2011-03-17 |
Biogen Ma Inc. |
Treating and evaluating inflammatory disorders
|
KR101679468B1
(ko)
|
2005-05-27 |
2016-11-24 |
바이오젠 엠에이 인코포레이티드 |
Tweak 결합 항체
|
WO2006130429A2
(en)
|
2005-05-27 |
2006-12-07 |
Biogen Idec Ma Inc. |
Treatment of cancer
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
AU2006261442A1
(en)
|
2005-06-24 |
2006-12-28 |
Novozymes A/S |
Lipases for pharmaceutical use
|
PT2452694T
(pt)
|
2005-06-30 |
2019-02-21 |
Janssen Biotech Inc |
Anticorpos anti-il-23, composições, métodos e utilizações
|
DK2239327T3
(en)
|
2005-08-11 |
2015-05-18 |
Synthetic Genomics Inc |
A method for in vitro recombination
|
EP2495257A3
(en)
*
|
2005-08-19 |
2012-10-17 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US20090215992A1
(en)
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
CN103204935B
(zh)
|
2005-08-26 |
2014-12-10 |
罗氏格黎卡特股份公司 |
具有改变的细胞信号传导活性的修饰的抗原结合分子
|
US7906116B2
(en)
|
2005-09-01 |
2011-03-15 |
Parkash Gill |
Methods for using and identifying modulators of Delta-like 4
|
CA2623648C
(en)
|
2005-09-21 |
2018-05-22 |
The Regents Of The University Of California |
Systems, compositions, and methods for local imaging and treatment of pain
|
EP1926752A2
(en)
|
2005-09-23 |
2008-06-04 |
Walter Reed Army Institute of Research (WRAIR) |
Antibodies with simultaneous subsite specificities to protein and lipid epitopes
|
EP3178850B1
(en)
|
2005-10-11 |
2021-01-13 |
Amgen Research (Munich) GmbH |
Compositions comprising cross-species-specific antibodies and uses thereof
|
CA2524005A1
(en)
|
2005-10-17 |
2007-04-17 |
Yen-Kai Ting |
Microwavable composite material and fabrication method thereof
|
EP1945771A1
(en)
|
2005-10-28 |
2008-07-23 |
Novo Nordisk A/S |
Fusion proteins that bind effector lymphocytes and target cells
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
TW200736277A
(en)
|
2005-11-14 |
2007-10-01 |
Amgen Inc |
RANKL antibody-PTH/PTHrP chimeric molecules
|
EP3023497A1
(en)
|
2005-11-18 |
2016-05-25 |
Glenmark Pharmaceuticals S.A. |
Anti-alpha2 integrin antibodies and their uses
|
CA2627446A1
(en)
|
2005-11-21 |
2007-05-31 |
Laboratoires Serono S.A. |
Compositions and methods of producing hybrid antigen binding molecules and uses thereof
|
PL1954718T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Przeciwciała skierowane przeciwko A globulomerowi, ich reszty wiążące antygeny, odpowiednie hybrydomy, kwasy nukleinowe, wektory, komórki gospodarze, sposoby wytwarzania tych przeciwciał, kompozycje zawierające te przeciwciała, zastosowania tych przeciwciał i sposoby stosowania tych przeciwciał
|
RU2492185C2
(ru)
|
2005-12-13 |
2013-09-10 |
Астразенека Аб |
Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
US8688495B2
(en)
|
2005-12-30 |
2014-04-01 |
Sap Ag |
Architectural design for time recording application software
|
AU2007208340B2
(en)
|
2006-01-23 |
2012-11-01 |
Joseph P. Errico |
Methods and compositions of targeted drug development
|
US8377691B2
(en)
|
2006-01-26 |
2013-02-19 |
Integral Molecular, Inc. |
Lipoparticles comprising ion channels, methods of making and using the same
|
AU2007235199B8
(en)
|
2006-01-31 |
2010-10-28 |
Novartis Ag |
IL-17 antagonistic antibodies for treating cancer
|
EP1991252A2
(en)
|
2006-02-21 |
2008-11-19 |
Oklahoma Medical Research Foundation |
Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
|
US20070207171A1
(en)
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
SG170750A1
(en)
|
2006-03-17 |
2011-05-30 |
Biogen Idec Inc |
Stabilized polypeptide compositions
|
BRPI0708970A2
(pt)
|
2006-03-21 |
2011-06-21 |
Wyeth Corp |
método para o tratamento de um sujeito com uma doença ou transtorno caracterizado por depósito amilóide de a-beta; método de inibição ou redução da acumulação de depósito amilóide de a-beta em um sujeito; método de inibição ou redução da neurodegeneração em um sujeito; e método de inibição ou redução do declìnio cognitivo, ou de melhora da cognição, em um sujeito
|
AU2007229698B9
(en)
|
2006-03-24 |
2012-11-08 |
Merck Patent Gmbh |
Engineered heterodimeric protein domains
|
AU2007245164A1
(en)
|
2006-03-28 |
2007-11-08 |
Biogen Idec Ma Inc. |
Anti-IGF-IR antibodies and uses thereof
|
US20070232556A1
(en)
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
EP2010213A4
(en)
|
2006-04-10 |
2010-08-11 |
Abbott Biotech Ltd |
USE AND COMPOSITIONS FOR THE TREATMENT OF JUVENIL RHEUMATOID ARTHRITIS
|
EP2377553A1
(en)
|
2006-04-14 |
2011-10-19 |
Novartis AG |
Use of IL-1 antibodies for treating ophthalmic disorders
|
KR101317235B1
(ko)
|
2006-04-21 |
2013-10-15 |
조마 테크놀로지 리미티드 |
길항제 항-cd40 항체 제약 조성물
|
WO2007124019A2
(en)
|
2006-04-21 |
2007-11-01 |
Gtc Biotherapeutics, Inc. |
Methods and products related to the transfer of molecules from blood to the mammary gland
|
US20070254338A1
(en)
|
2006-04-24 |
2007-11-01 |
Amgen Inc. |
Method for making recombinant protein using complementation dependent DHFR mutants
|
US20080118978A1
(en)
|
2006-04-28 |
2008-05-22 |
Takashi Sato |
Anti-tumor agent
|
CN101058609B
(zh)
|
2006-05-26 |
2011-04-13 |
神州细胞工程有限公司 |
人源抗体及其表达
|
AU2007254853B2
(en)
|
2006-06-02 |
2011-11-17 |
Aveo Pharmaceuticals, Inc. |
Hepatocyte growth factor (HGF) binding proteins
|
SG175615A1
(en)
|
2006-06-06 |
2011-11-28 |
Genentech Inc |
Anti-dll4 antibodies and methods using same
|
KR20090016762A
(ko)
|
2006-06-06 |
2009-02-17 |
제넨테크, 인크. |
혈관 발달을 조정하기 위한 조성물 및 방법
|
CN1884517B
(zh)
|
2006-06-08 |
2010-06-30 |
武汉禾元生物科技有限公司 |
利用谷物非储藏蛋白为融合载体在胚乳表达多肽的方法及应用
|
EP2035456A1
(en)
|
2006-06-22 |
2009-03-18 |
Novo Nordisk A/S |
Production of bispecific antibodies
|
ATE537450T1
(de)
|
2006-06-30 |
2011-12-15 |
Schering Corp |
Igfbp2-biomarker
|
US20080081379A1
(en)
|
2006-07-13 |
2008-04-03 |
Sigler Gerald F |
Homogeneous double receptor agglutination assay for immunosuppressant drugs
|
PL2046833T3
(pl)
|
2006-07-14 |
2014-01-31 |
Ac Immune Sa |
Humanizowane przeciwciało przeciw amyloidowi beta
|
US7592156B2
(en)
|
2006-07-20 |
2009-09-22 |
Wyeth |
Synthetic dog/human chimeric C-C chemokine receptor 2B
|
EP2049670A1
(en)
|
2006-08-11 |
2009-04-22 |
Monsanto Technology, LLC |
Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase
|
EP2383297B8
(en)
|
2006-08-14 |
2023-03-22 |
Xencor, Inc. |
Optimized antibodies that target CD19
|
SI3339445T1
(sl)
|
2006-09-08 |
2020-12-31 |
Abbvie Bahamas Ltd. |
Beljakovine za vezavo interlevkin-13
|
US20080075690A1
(en)
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
RS54452B1
(en)
|
2006-09-29 |
2016-06-30 |
Oncomed Pharmaceuticals, Inc. |
INGREDIENTS AND PROCEDURES FOR DIAGNOSIS AND TREATMENT OF CANCER
|
US20080102475A1
(en)
|
2006-10-13 |
2008-05-01 |
Zhengyan Kan |
Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)
|
WO2008057240A2
(en)
|
2006-10-27 |
2008-05-15 |
Abbott Biotechnology Ltd. |
Crystalline anti-htnfalpha antibodies
|
EP2097455B1
(en)
*
|
2006-11-02 |
2014-10-22 |
Genentech, Inc. |
Humanized anti-factor d antibodies
|
EP2120996A2
(en)
|
2006-12-20 |
2009-11-25 |
Vasgene Therapeutics, Inc. |
Methods for using and identifying modulators of delta-like 4
|
DE602008004296D1
(de)
*
|
2007-02-14 |
2011-02-17 |
Vaccinex Inc |
Humanisierte anti-cd100-antikörper
|
EP3248617A3
(en)
|
2007-02-16 |
2018-02-21 |
Merrimack Pharmaceuticals, Inc. |
Antibodies against erbb3 and uses thereof
|
EA019636B1
(ru)
|
2007-03-22 |
2014-05-30 |
Байоджен Айдек Ма Инк. |
Связывающие белки, включающие антитела, производные антител и фрагменты антител, которые специфически связываются с cd154, и их применения
|
US7906293B2
(en)
|
2007-04-09 |
2011-03-15 |
Abbott Laboratories |
Acridinium phenyl esters useful in the analysis of biological
|
RU2009140134A
(ru)
|
2007-04-23 |
2011-05-27 |
Вайет (Us) |
Способы и композиции для лечения и мониторинга лечения связанных с ил-13 нарушений
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
EP1997832A1
(en)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against Claudin-18 for treatment of cancer
|
US8158124B2
(en)
|
2007-05-30 |
2012-04-17 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
US8227201B2
(en)
|
2007-06-27 |
2012-07-24 |
Board Of Trustees Of The Leland Stanford Junior University |
BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease
|
KR20100058509A
(ko)
|
2007-07-31 |
2010-06-03 |
메디뮨 엘엘씨 |
다중특이적 에피토프 결합 단백질 및 이의 용도
|
RU2010107994A
(ru)
|
2007-08-08 |
2011-09-20 |
Эбботт Лэборетриз (Us) |
Композиции и способы кристаллизации антител
|
WO2009021754A2
(en)
|
2007-08-15 |
2009-02-19 |
Bayer Schering Pharma Aktiengesellschaft |
Monospecific and multispecific antibodies and method of use
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
CA2702611A1
(en)
|
2007-10-19 |
2009-04-23 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|
BRPI0822049B1
(pt)
|
2007-12-17 |
2021-11-16 |
Pfizer Limited |
Composiqao farmaceutica compreendendo anticorpo antagonista anti-ngf, kit e uso de um anticorpo antingf
|
WO2009089004A1
(en)
|
2008-01-07 |
2009-07-16 |
Amgen Inc. |
Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
|
BRPI0906490A2
(pt)
|
2008-01-15 |
2015-07-14 |
Abbott Lab |
Vetores de expressão de mamífero melhorados e uso dos mesmos
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
JP5646457B2
(ja)
|
2008-04-29 |
2014-12-24 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリン及びその使用
|
US20100260668A1
(en)
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
JP5890174B2
(ja)
|
2008-05-09 |
2016-03-22 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
終末糖化産物受容体(rage)に対する抗体及びその使用
|
KR20110016959A
(ko)
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
EP3002299A1
(en)
|
2008-06-03 |
2016-04-06 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US8741287B2
(en)
|
2008-06-18 |
2014-06-03 |
Abbott Laboratories |
PlGF-1 assay and kits and components thereof
|
AU2009268585C1
(en)
|
2008-07-08 |
2014-10-02 |
Abbvie Inc. |
Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
|
EP2310049A4
(en)
|
2008-07-08 |
2013-06-26 |
Abbvie Inc |
PROSTAGLANDIN E2 BINDING PROTEINS AND USES THEREOF
|
WO2010017103A2
(en)
|
2008-08-04 |
2010-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Fully human anti-human nkg2d monoclonal antibodies
|
BRPI0919426A2
(pt)
|
2008-09-30 |
2015-12-15 |
Abbott Lab |
métodos melhorado de exposição de rna
|
US8268314B2
(en)
|
2008-10-08 |
2012-09-18 |
Hoffmann-La Roche Inc. |
Bispecific anti-VEGF/anti-ANG-2 antibodies
|
MX2011005953A
(es)
|
2008-12-04 |
2011-08-17 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual y usos de las mismas.
|
RU2015132478A
(ru)
|
2009-03-05 |
2015-12-10 |
Эббви Инк. |
Связывающие il-17 белки
|
UY32603A
(es)
|
2009-05-01 |
2010-12-31 |
Abbott Lab |
Inmunoglobulina con dominio variable dual y usos de la misma
|
KR20140014382A
(ko)
|
2009-05-01 |
2014-02-06 |
애브비 인코포레이티드 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
UY32808A
(es)
|
2009-07-29 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas como dominio variable dual y usos de las mismas
|
RU2570639C2
(ru)
|
2009-08-29 |
2015-12-10 |
Эббви Инк |
Терапевтические dll4-связывающие белки
|
RU2012112550A
(ru)
|
2009-09-01 |
2013-10-10 |
Эбботт Лэборетриз |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
US20110172398A1
(en)
|
2009-10-02 |
2011-07-14 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules for anti-angiogenesis therapy
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
JP2013507929A
(ja)
*
|
2009-10-15 |
2013-03-07 |
アボット・ラボラトリーズ |
Il−1結合蛋白質
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
WO2011084714A2
(en)
|
2009-12-17 |
2011-07-14 |
Biogen Idec Ma Inc. |
STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF
|
BR112012016736A2
(pt)
|
2010-01-22 |
2016-12-13 |
Hoffmann La Roche |
composição , formulação farmacêutica e uso da composição"
|
AU2011223919B2
(en)
|
2010-03-02 |
2015-03-19 |
Abbvie Inc. |
Therapeutic DLL4 binding proteins
|
BR122014011544A2
(pt)
*
|
2010-05-14 |
2019-08-13 |
Abbvie Inc |
proteínas de ligação à il-1
|
TW201204831A
(en)
|
2010-06-24 |
2012-02-01 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
MY160445A
(en)
|
2010-08-03 |
2017-03-15 |
Abbvie Inc |
Dual Variable Domain Immunoglobulins And Uses Thereof
|
RU2013113225A
(ru)
|
2010-08-26 |
2014-10-10 |
Эббви Инк. |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
AU2011323521A1
(en)
|
2010-11-02 |
2013-06-20 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
UY33707A
(es)
|
2010-11-04 |
2012-05-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
SI2646470T1
(sl)
|
2010-11-30 |
2017-05-31 |
F. Hoffmann-La Roche Ag |
Protitelesa proti receptorjem antitransferina in njihova uporaba za prenos terapevtskega enoverižnega variabilnega fragmenta (scfv) prek krvno-možganske pregrade
|
BR112013015944A2
(pt)
|
2010-12-21 |
2018-06-19 |
Abbvie Inc |
imunoglobulinas de domínio duplo variável il-1 alpha e beta biespecífico e seus usos.
|
US20120201746A1
(en)
|
2010-12-22 |
2012-08-09 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
KR20150080033A
(ko)
|
2011-02-08 |
2015-07-08 |
애브비 인코포레이티드 |
골관절염 및 통증의 치료 방법
|
RU2013150331A
(ru)
|
2011-04-20 |
2015-05-27 |
Рош Гликарт Аг |
СПОСОБ И УСТРОЙСТВА ДЛЯ рН-ЗАВИСИМОГО ПРОХОЖДЕНИЯ ГЕМАТОЭНЦЕФАЛИЧЕСКОГО БАРЬЕРА
|
PL2758073T3
(pl)
|
2011-09-23 |
2019-04-30 |
Oncomed Pharm Inc |
Środki wiążące VEGF/DLL4 i ich zastosowania
|
MX2014004981A
(es)
|
2011-10-24 |
2014-09-11 |
Abbvie Inc |
Inmunoaglutinantes dirigidos contra tnf.
|
MX2014004980A
(es)
|
2011-10-24 |
2014-09-11 |
Abbvie Inc |
Inmunoaglutinantes biespecificos dirigidos contra tnf e il-17.
|
CN104203978A
(zh)
|
2011-10-24 |
2014-12-10 |
艾伯维股份有限公司 |
针对硬化蛋白的免疫结合剂
|
EP2782601A4
(en)
|
2011-11-21 |
2015-09-16 |
Abbvie Inc |
IL-1 BINDING PROTEINS
|
CA2862433A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
JP2015508994A
(ja)
|
2011-12-30 |
2015-03-26 |
アッヴィ・インコーポレイテッド |
Il−13および/またはil−17に対する二重可変ドメイン免疫グロブリン
|
EP2915818A3
(en)
|
2011-12-30 |
2015-11-11 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
LT2807192T
(lt)
|
2012-01-27 |
2018-07-25 |
AbbVie Deutschland GmbH & Co. KG |
Kompozicijos ir būdai, skirti ligų, susijusių su neuritų degeneracija, diagnostikai ir gydymui
|
SG11201407669QA
(en)
|
2012-05-21 |
2014-12-30 |
Genentech Inc |
Methods for improving safety of blood-brain barrier transport
|
NZ703585A
(en)
|
2012-08-29 |
2018-03-23 |
Hoffmann La Roche |
Blood brain barrier shuttle
|
KR20190096459A
(ko)
|
2012-11-01 |
2019-08-19 |
애브비 인코포레이티드 |
항-vegf/dll4 이원 가변 도메인 면역글로불린 및 이의 용도
|
TW202033215A
(zh)
|
2012-11-01 |
2020-09-16 |
美商艾伯維有限公司 |
穩定雙重可變區域免疫球蛋白蛋白質調配物
|
US20140212423A1
(en)
|
2012-12-04 |
2014-07-31 |
Abbvie, Inc. |
Blood-brain barrier penetrating dual specific binding proteins
|
US20140213771A1
(en)
|
2012-12-28 |
2014-07-31 |
Abbvie, Inc. |
Multi-specific binding proteins
|
WO2014106001A2
(en)
|
2012-12-28 |
2014-07-03 |
Abbvie, Inc. |
Dual specific binding proteins having a receptor sequence
|
US9856319B2
(en)
|
2012-12-28 |
2018-01-02 |
Abbvie Inc. |
Monovalent binding proteins
|
US20140235476A1
(en)
|
2012-12-28 |
2014-08-21 |
Abbvie, Inc. |
Multivalent binding protein compositions and methods for identifying variants of same
|
US9458244B2
(en)
|
2012-12-28 |
2016-10-04 |
Abbvie Inc. |
Single chain multivalent binding protein compositions and methods
|
JP2016510319A
(ja)
|
2012-12-28 |
2016-04-07 |
アッヴィ・インコーポレイテッド |
多価結合タンパク質組成物
|
US20140213772A1
(en)
|
2012-12-28 |
2014-07-31 |
Abbvie, Inc. |
Cross-over dual variable domain immunoglobulin constructs
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
JP2016517277A
(ja)
|
2013-03-15 |
2016-06-16 |
アッヴィ・インコーポレイテッド |
TNFαに対して指向された二重特異的結合タンパク質
|
MX2015013166A
(es)
|
2013-03-15 |
2015-12-11 |
Abbvie Inc |
Proteinas de union especificas duales dirigidas contra il-1 beta y/o il-17.
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
SG11201600807YA
(en)
|
2013-08-02 |
2016-03-30 |
Hoffmann La Roche |
Therapeutic fusion protein
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
US20150291689A1
(en)
|
2014-03-09 |
2015-10-15 |
Abbvie, Inc. |
Compositions and Methods for Treating Rheumatoid Arthritis
|
US20160002343A1
(en)
|
2014-06-11 |
2016-01-07 |
Abbvie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|